Core Scientific Inc (CORZ) AI Stock Analysis

• Market Cap: $4.26B
• Dividend Yield: N/A
• Average Volume (3M): 20.15M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.88
• Revenue Growth: -26.76%
• EPS Growth: -1883.89%
• Country: US
• Employees: 325
• Sector: General
• Sector Strength: N/A
• Industry: Software - Infrastructure
• EPS (TTM): 1.25
• Shares Outstanding: 303,694,180
• 10 Day Avg. Volume: 39,543,166
• 30 Day Avg. Volume: 20,149,389
• PEG Ratio: <0.01
• Price to Book (P/B): -2.86
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -6.55
• Enterprise Value/Market Cap: 0.27
• Enterprise Value/Revenue: 0.56
• Enterprise Value/Gross Profit: 22.41
• Enterprise Value/Ebitda: -0.27
• 1Y Price Target: $17.59
• Price Target Upside: 25.46% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 14

• Rating: 56 Neutral
• Price Target: $15.50 ▲(10.56%Upside)

The overall stock score reflects significant financial challenges and a weak valuation, which are partially offset by positive technical momentum and strategic corporate events. The merger with CoreWeave offers potential long-term benefits, but current financial instability remains a major concern.

Positive Factors

Cost Savings

CoreWeave's management targets annual cost savings above $500M as the Core Scientific lease overhead disappears and operating synergies build.

Growth Opportunities

CRWV has access to in-demand GPUs and HPC data centers, which are expected to drive a multi-year growth story for the industry.

Investor Confidence

Growing market comfort with CoreWeave as a counterparty is contributing to increased investor confidence in Core Scientific.

Negative Factors

Acquisition Concerns

The acquisition deal was expected to include a cash component, but it ended up being an all-stock agreement, which disappointed many CORZ investors.

Legal Investigations

Law firms have already announced investigations into whether CORZ management/board breached fiduciary duties.

Ownership Dilution

CORZ shareholders will receive a smaller ownership percentage in the new entity than expected, with only about 10% ownership.

Core Scientific Inc Business Overview & Revenue Model

Company Description

Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting. The company owns and operates computer equipment that is used to process transactions conducted on one or more blockchain networks in exchange for transaction processing fees rewarded in digital currency assets, commonly referred to as mining; and datacenter facilities to provide colocation and hosting services for distributed ledger technology, also commonly known as blockchain. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. The company is headquartered in Austin, Texas. On December 21, 2022, Core Scientific, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

How the Company Makes Money

Core Scientific Inc primarily makes money through its digital asset mining operations and hosting services. The company generates revenue by mining cryptocurrencies, which involves solving complex computational problems to validate transactions on a blockchain network, earning digital assets as a reward. Additionally, Core Scientific provides hosting and management services for other cryptocurrency miners, charging fees for the use of its infrastructure and expertise. The company leverages its large-scale data centers and advanced technology solutions to optimize mining efficiency and profitability. Strategic partnerships with technology providers and energy companies also play a significant role in enhancing its operational capabilities and reducing costs.

Core Scientific Inc Financial Statement Overview

Summary

Core Scientific Inc is grappling with severe financial difficulties. The company reports declining revenues, negative profit margins, and high leverage, all of which contribute to a weak financial position. Operational cash flow challenges further exacerbate the situation, signaling significant financial instability.

Income Statement

Core Scientific Inc has experienced a significant decline in financial performance. Revenue has been decreasing, with a negative revenue growth rate from 2022 to 2023. Margins have deteriorated, with gross profit margin slipping and the net profit margin deeply negative, indicating substantial losses. EBIT and EBITDA margins are negative, highlighting operational inefficiencies and challenges in covering operating expenses.

Balance Sheet

The balance sheet of Core Scientific Inc shows financial instability. The company has negative stockholders' equity, indicating liabilities exceed assets. The high debt-to-equity ratio and negative equity ratio suggest a highly leveraged position, which poses significant financial risk. Return on Equity is negative due to consistent net losses, further reflecting poor financial health.

Cash Flow

Cash flow analysis reveals operational challenges, as seen by negative operating cash flow in the TTM period. Free cash flow is also negative, indicating cash outflows exceed inflows. The operating cash flow to net income ratio is unfavorable, reflecting cash generation issues. Despite occasional positive financing cash flows, the overall cash flow situation remains concerning.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	410.91M	510.67M	502.40M	640.31M	544.48M	60.32M
Gross Profit	51.64M	121.07M	123.46M	8.40M	238.86M	9.39M
EBITDA	-1.46B	-1.16B	-63.12M	-1.84B	167.61M	-10.40K
Net Income	-945.00M	-1.32B	-246.49M	-2.15B	47.31M	-10.40K
Balance Sheet
Total Assets	1.63B	1.60B	712.16M	807.69M	2.44B	225.58M
Cash, Cash Equivalents and Short-Term Investments	697.94M	836.20M	50.41M	52.24M	131.68M	8.67M
Total Debt	1.19B	1.20B	865.54M	37.73M	818.81M	40.29M
Total Liabilities	1.81B	2.42B	1.31B	1.22B	1.05B	136.35M
Stockholders Equity	-181.51M	-820.18M	-596.94M	-409.35M	1.39B	89.22M
Cash Flow
Free Cash Flow	-171.60M	-52.06M	48.95M	-178.79M	-116.01M	-25.33M
Operating Cash Flow	-19.88M	42.90M	65.11M	205.19M	-56.73M	-23.77M
Investing Cash Flow	-156.68M	-95.19M	-3.00M	-590.78M	-423.84M	-15.14M
Financing Cash Flow	761.01M	819.57M	-44.65M	306.15M	603.53M	40.72M

Core Scientific Inc Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 14.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CORZ, the sentiment is Neutral. The current price of 14.02 is above the 20-day moving average (MA) of 13.89, above the 50-day MA of 11.73, and above the 200-day MA of 12.21, indicating a neutral trend. The MACD of 1.13 indicates Positive momentum. The RSI at 49.00 is Neutral, neither overbought nor oversold. The STOCH value of 36.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CORZ.

Core Scientific Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DLO	81 Outperform	$3.24B	25.20	26.10%	―	―	―
STNE	66 Neutral	$4.35B	8.73	-8.85%	―	-14.03%	-167.03%
AVPT	65 Neutral	$3.79B	―	-8.39%	―	21.70%	-67.95%
DOCN	64 Neutral	$2.68B	27.32	-41.63%	―	13.21%	109.61%
Sector *	57 Neutral	$5.65B	22.83	-28.61%	5.63%	10.25%	-31.59%
CORZ	56 Neutral	$4.26B	―	160.33%	―	-26.76%	-1883.89%
BKKT	56 Neutral	$247.99M	―	-60.94%	―	128.83%	73.67%

Core Scientific Inc Corporate Events

Core Scientific Inc Announces Merger with CoreWeave

On July 7, 2025, Core Scientific, Inc. entered into a merger agreement with CoreWeave, Inc., where Core Scientific will become a wholly-owned subsidiary of CoreWeave. The merger involves an exchange of shares and the conversion of stock options and awards, with conditions including regulatory approvals and shareholder votes. This merger is expected to enhance Core Scientific’s market positioning and operational capabilities, impacting stakeholders through potential synergies and strategic alignment in the high-performance computing and digital asset sectors.

The most recent analyst rating on (CORZ) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Merges with CoreWeave in $9 Billion Deal

On July 7, 2025, CoreWeave and Core Scientific announced a merger agreement where CoreWeave will acquire Core Scientific in an all-stock transaction. This acquisition aims to enhance CoreWeave’s data center capabilities, improve operational efficiency, and expand their power footprint, ultimately solidifying their growth trajectory in AI and HPC workloads. The transaction, expected to close in the fourth quarter of 2025, will result in significant cost savings and strategic benefits, including greater financing flexibility and expanded expertise. Core Scientific’s stockholders will receive shares of CoreWeave Class A common stock, with the merger valued at approximately $9 billion.

The most recent analyst rating on (CORZ) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Inc Restructures Post-Bankruptcy Governance

On May 23, 2025, Core Scientific, Inc. held its reconvened 2025 Annual Meeting of Stockholders to vote on amendments to its Certificate of Incorporation. The stockholders approved proposals to eliminate the classification of the Board of Directors, remove the supermajority vote requirements, and eliminate certain consent rights provided to creditors, which are significant steps in the company’s restructuring process following its emergence from bankruptcy.

The most recent analyst rating on (CORZ) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Appoints Elizabeth Crain to Board

On May 13, 2025, Todd Becker resigned from the Board of Directors of Core Scientific, Inc., having served since January 2024 and played a key role in strengthening the company’s financial foundation. The following day, Elizabeth Crain was appointed to the Board and as Chair of the Audit Committee, bringing extensive experience from her previous roles at Consello Group and Moelis & Company. Her appointment is expected to further bolster the company’s strategic direction and governance.

The most recent analyst rating on (CORZ) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Inc Holds Annual Stockholders Meeting

On May 12, 2025, Core Scientific, Inc. held its Annual Meeting of Stockholders, where key proposals were voted on, including the election of a board nominee and the approval of executive compensation. The meeting also addressed the frequency of advisory votes on executive compensation, with stockholders opting for annual votes. Additionally, the meeting was adjourned to May 23, 2025, to consider amendments to the company’s Certificate of Incorporation, aimed at eliminating board classification and supermajority vote requirements, as well as removing certain creditor consent rights.

The most recent analyst rating on (CORZ) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Reports Strong Q1 2025 Net Income

Core Scientific reported its fiscal first quarter 2025 results, highlighting a net income of $580.7 million, a significant increase from the previous year primarily due to a non-cash mark-to-market adjustment. Despite a decrease in total revenue and operating loss, the company maintains strong liquidity and is on track to expand its colocation services, positioning itself for growth in high-performance data infrastructure.

Core Scientific Inc Increases CEO’s Annual Salary

On April 28, 2025, Core Scientific Inc.’s Compensation Committee approved an increase in the annual base salary of their CEO, Adam Sullivan, to $825,000 for the 2025 calendar year. This adjustment acknowledges Sullivan’s contributions and aligns his salary with the company’s competitive compensation strategy.